Trials / Sponsors / Kiromic BioPharma Inc.
Kiromic BioPharma Inc.
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advance Carcinoma, Non-Small-Cell Lung Cancer, Bone Metastases From Solid Tumors | Phase 1 | 2023-11-07 |
| Terminated | Cyclophosphamide, TAPA-Pulsed Dendritic Cell Therapy and Imiquimod in Progressive and/or Refractory Solid Mali Progressive Solid Malignancies, Refractory Solid Malignancies, Cancer | Phase 1 / Phase 2 | 2017-07-28 |
| Withdrawn | Consolidation Therapy in Patients With Hematologic Malignancies Cancer, Hematologic Malignancies | Phase 1 / Phase 2 | 2017-07-28 |
| Withdrawn | Consolidation Therapy in Patients With Metastatic Solid Malignancies Cancer, Metastatic Solid Malignancies | Phase 1 / Phase 2 | 2017-07-28 |
| Withdrawn | Therapy for Progressive and/or Refractory Hematologic Malignancies Cancer, Hematologic Malignancies | Phase 1 / Phase 2 | 2017-07-28 |